Literature DB >> 27928307

The Pseudotumor Cerebri Syndrome: A Unifying Pathophysiological Concept for Patients with Isolated Intracranial Hypertension with Neither Mass Lesion Nor Ventriculomegaly.

G M Halmagyi1, R M Ahmed1, I H Johnston2.   

Abstract

In 1991 we proposed that while the syndrome of isolated intracranial hypertension might have many definite and probable causes, it has nonetheless a single unifying pathophysiological mechanism: namely, impairment of cerebrospinal fluid (CSF) reabsorption. For that reason, we also proposed then that it is best described by a single, unifying, inclusive term, namely, pseudotumor cerebri syndrome. Although it appears that there is, as far as nomenclature is concerned, now international agreement, there is as yet no agreement on pathophysiology and classification. Herein we outline our views on these matters and give our reasons.

Entities:  

Keywords:  Benign intracranial hypertension; idiopathic intracranial hypertension; otitic hydrocephalus; pseudotumor cerebri

Year:  2014        PMID: 27928307      PMCID: PMC5123177          DOI: 10.3109/01658107.2014.886705

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  37 in total

1.  Otitic hydrocephalus.

Authors:  C SYMONDS
Journal:  Neurology       Date:  1956-10       Impact factor: 9.910

2.  Nomenclature in intracranial pressure.

Authors:  M P Rozear
Journal:  N Engl J Med       Date:  1969-07-03       Impact factor: 91.245

3.  Hydrocephalus in tuberculous meningitis: Incidence, its predictive factors and impact on the prognosis.

Authors:  Tushar Raut; Ravindra Kumar Garg; Amita Jain; Rajesh Verma; Maneesh Kumar Singh; Hardeep Singh Malhotra; Neera Kohli; Anit Parihar
Journal:  J Infect       Date:  2013-01-02       Impact factor: 6.072

4.  The outcome of pseudotumor cerebri induced by tetracycline therapy.

Authors:  A Kesler; Y Goldhammer; A Hadayer; P Pianka
Journal:  Acta Neurol Scand       Date:  2004-12       Impact factor: 3.209

Review 5.  Recurrent benign intracranial hypertension due to iron deficiency anemia. Case report and review of the literature.

Authors:  O Tugal; R Jacobson; S Berezin; S Foreman; S Berezin; A Brudnicki; L Godine; M M Davidian; S Jayabose; V Escobedo
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-08

6.  Idiopathic hydrocephalus in children and idiopathic intracranial hypertension in adults: two manifestations of the same pathophysiological process?

Authors:  Grant A Bateman; Robert L Smith; Sabbir H Siddique
Journal:  J Neurosurg       Date:  2007-12       Impact factor: 5.115

7.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

8.  Time course of intraventricular pressure change in a canine model of hydrocephalus: its relationship to sagittal sinus elastance.

Authors:  J M McCormick; K Yamada; H L Rekate; H Miyake
Journal:  Pediatr Neurosurg       Date:  1992       Impact factor: 1.162

9.  The role of venous sinus outflow obstruction in pediatric idiopathic intracranial hypertension.

Authors:  Christopher M Dwyer; Kristina Prelog; Brian K Owler
Journal:  J Neurosurg Pediatr       Date:  2012-11-23       Impact factor: 2.375

10.  Malignant meningitis presenting as pseudotumor cerebri.

Authors:  R M Ahmed; G M Halmagyi
Journal:  J Neurol Sci       Date:  2013-04-09       Impact factor: 3.181

View more
  2 in total

1.  Increased Incidence of Pseudotumor Cerebri Syndrome Among Users of Tetracycline Antibiotics.

Authors:  Samuel F Passi; Ryan Butcher; Daniel R Orme; Judith E A Warner; Gregory J Stoddard; Alison V Crum; Ramkiran Gouripeddi; Brian H Kirk; Kathleen B Digre; Bradley J Katz
Journal:  J Neuroophthalmol       Date:  2022-03-25       Impact factor: 4.415

2.  A 43-year-old woman presenting with subacute, bilateral, sequential facial nerve palsies, then developing pseudotumour cerebri.

Authors:  Laura O'Connor; Glen Croxson; Peter McCluskey; Gabor Michael Halmagyi
Journal:  BMJ Case Rep       Date:  2015-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.